Oppenheimer Assumes Aquestive Therapeutics (AQST) at Outperform
Oppenheimer analyst Mazahir Alimohamed assumes coverage on Aquestive Therapeutics (NASDAQ: AQST) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
